Navigation Links
VICAM's New Immunoassay Column Detects Seven Mycotoxins in Single Run
Date:4/2/2013

MILFORD, Mass., April 2, 2013 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced that VICAM®, a Waters® Business, introduced the Myco6in1+™ LC/MS/MS immunoaffinity (IA) column, the only IA column on the market to simultaneously screen for seven major mycotoxin families isolating at least 14 chemically-distinct mycotoxins, including aflatoxin, ochratoxin A, fumonisin, deoxynivalenol, zearalenone, T-2, HT-2, and nivalenol.

(Logo: http://photos.prnewswire.com/prnh/20110707/NE31586LOGO )

Created by VICAM, the world's leading provider of mycotoxin testing solutions, the Myco6in1+ column is a quantitative tool which combines the proven strengths of selective monoclonal antibodies and liquid chromatography with tandem mass spectrometry. It is designed to deliver precise numerical results, with a recovery rate greater than 90%.

Marjorie Radlo-Zandi , General Manager, Director of Operations of VICAM said, "VICAM's patented Myco6n1+ technology provides both ease of use and superior recovery. This provides analytic labs with an effective tool in order to test for multiple mycotoxins even with the most complex of commodity matrices. Our patented new multi-analyte column provides superior measurable results, while also giving sample throughput and overall efficiency a major boost."  

The Myco6in1+ column requires only one sample and a single pass through the column, minimizing time and materials costs while improving laboratory productivity. Independent labs can now use it as a routine analysis tool because it is fast and simple with excellent recoveries.

Mycotoxins are naturally occurring chemical byproducts of ubiquitous mold species which are natural inhabitants of crop soils. Severe rain or drought can encourage mycotoxin production and, once released, mycotoxins are difficult to manage and virtually impossible to destroy.  The USDA, FDA, EU, and other international government agencies impose specific regulations and guidelines for acceptable levels of mycotoxins. Producers and exporters use on site and laboratory testing to ensure regulatory compliance and to protect human and animal health.

For more information on the Myco6in1+ column, please visit www.vicam.com/myco

About VICAM, A Waters Business (www.vicam.com)

VICAM is a world-leading provider of mycotoxin testing solutions. Since 1985, VICAM has been dedicated to developing USDA- and AOAC-approved rapid tests for mycotoxins. VICAM's mycotoxin test kits offer a choice of rapid qualitative screening and quantitative test methods for a wide variety of mycotoxins. Around the world, VICAM products are used with confidence by customers who trust our commitment to extending the value of those products with unmatched service and support. We guarantee satisfaction with expert technical assistance and top-of-the-line customer care through a global scientific and distribution network that develops, markets, sells, and services our products in more than 100 countries. For more information, please visit www.vicam.com or call +1.508.482.4935.

About Waters Corporation (www.waters.com)

Waters Corporation (NYSE: WAT) creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters' technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.84 billion in 2012, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters and VICAM are registered trademarks of Waters Corporation.  Myco6in1+ is a trademark of Waters Corporation.


'/>"/>
SOURCE Waters Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
2. The Return of Extinct Animals – and Maybe Humans; Latest Topic by HuffPost Columnist and Sociologist Gini Graham Scott
3. Graphene foam detects explosives, emissions better than todays gas sensors
4. Study In Prenatal Diagnosis Finds Sequenom CMMs MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets
5. DNA Blood Test Detects Cancer Resistance Using Inostics BEAMing Technology
6. Electronic Headband That Detects and Treats Addictive In-Sleep Behavior to be Demonstrated at Annual Holistic Dental Conference by Holistic Technologies
7. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
8. NDIA, NTSA Will Be On Hand At Seventh Annual Capitol Hill Modeling and Simulation Expo, Set To Focus On Homeland Security, First Response
9. Sangamo BioSciences Announces Presentation at Seventh Annual JMP Securities Healthcare Conference
10. Seven Outstanding Doctors Receive Honors From The United States & Canadian Academy of Pathology
11. New England Biolabs opens seventh subsidiary in Singapore
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... NX Prenatal Inc., a US based ... for early warning of adverse pregnancy outcomes, announced ... by Dr. Thomas McElrath of Brigham ... Medicine,s (SMFM) annual meeting held in ... The presentation reported initial positive top-line results regarding ...
(Date:2/10/2016)... -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company ... for the treatment of prostate, brain, lung, head and ... for the second quarter and six months of fiscal ... --> --> Revenue was $1.19 ... ended December 31, 2015, a 12% increase compared to ...
(Date:2/10/2016)... ... 2016 , ... Benchmark Research, a fully-integrated network of ... principal investigators (PI) to the roles of Chief Medical Officer, Clinical Research and ... Chu, a Benchmark Research PI in the Austin office, will assume the role ...
(Date:2/10/2016)... ... February 10, 2016 , ... SonaCare Medical, LLC ... support program, Sonalink™ remote monitoring. The inaugural launch of this new technology occurred ... connecting Dr. Samuel Peretsman to a HIFU technical expert at SonaCare Medical headquarters. ...
Breaking Biology Technology:
(Date:2/2/2016)... YORK , Feb. 2, 2016 /PRNewswire/ ... facilities are primarily focused on medical screening ... measure point-of-care parameters. Wearable devices that facilitate ... user,s freedom of movement are being bolstered ... for human biomedical signal acquisition coupled with ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of that Rising Market Are you interested ... analysis forecasts revenues for checkpoint inhibitors. Visiongain,s report ... market, submarket, product and national level. Avoid ... discover what progress, opportunities and revenues those emerging ...
(Date:2/2/2016)... Va. , Feb. 2, 2016   ... award from the U.S. Army Research Office and ... the range and sensitivity of the company,s ... Past Accounting Mission and, more generally, defense-related DNA ... DNA phenotyping capabilities (predicting appearance and ancestry from ...
Breaking Biology News(10 mins):